Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Adverse reactions to drugs Medicines guidance (BNF)
doi:10.1007/978-1-60761-756-3_18 94. Palmen, S
Cardiovascular complications of diabetes: from microvascular to macrovascular pathways
Injection-site and quality-control risk Reported injection-site issues include redness, mild swelling, transient bruising, and occasional sterile abscess
First, in the absence of Albumax and drug, PS exposure of erythrocytes slowly increased over time, both in Ringer solution (24-fold increase after 48 h, p =0.0011) and in iRPMI (6.4-fold increase after 48 h, p =0.0068)
US$ 22.96
US$ 29.64
US$ 28.68
